GOTHENBURG, Sweden, May 22, 2025 /PRNewswire/ -- The seventh edition of the competition focused on the skills that make a real difference for productivity and sustainability in the modern transport business. The 2 key champions were Mr. Fatorrahman from Indonesia [Off-Road Category] and Mr. Euihwan Choi from Korea [On-Road Category].
The aim of the Driver Challenge is to draw attention to the important work done by truck drivers. It is also a way of attracting young people to the job, which offers good career opportunities. The transport industry is constantly growing and there is now a shortage of trained drivers all over the world. To help our customers to recruit and retain skilled drivers, we have been focusing for many years on the design of the driver's environment and the drivability of our trucks. The concept "You win, we all win" puts truck drivers in focus, highlighting the vital role they play in ensuring everybody wins. It reminds customers that there is always room for improvement when it comes to driving skills - and that it's well worth the effort.
The Volvo Trucks Driver Challenge brings together all the different challenges that truck drivers face every day. Their skills are often the decisive factor in the productivity and profitability of our customers. Drivers also make a major contribution to road safety. The finals gave us the opportunity to see incredibly skillful drivers doing an impressive job of handling their trucks.
Ms. Anna Engblom, Managing Director for Southeast Asia & Japan at Volvo Trucks said, "The Driver Challenge is our way of bringing Volvo's deep expertise in fuel economy to our customers, delivering these benefits throughout the entire lifespan and operation of their trucks. This competition empowers drivers to enhance their driving skills, improve fuel efficiency, and prioritize safety. Using less fuel is not only beneficial for our customers but also for the environment." She continued to say " Volvo Connect scores measure driver performance, providing a Fuel Efficiency Score based on speed adaptation, engine and gear utilization, anticipation and braking, and standstill. Striving for a high score reduces costs, CO2 emissions, and enhances safety and vehicle longevity – key aspects of the Drivers' Challenge."
The Volvo Trucks Driver Challenge has been running globally since 2009 and this year's competition attracted 13 markets in the Middle East, Asia, Oceania and Australia. In the sub-category segment, the winners for each were [On-Road & Off-Road]
- Best Fuel-Efficient Driving: Anthony Marshall, Australia & Sangyoun Park, Korea
- Best Transport Mission / High Productivity: Amnart Phengphet, Thailand & Ryan Balanueco, Philippines
- On-Time Delivery: Bedirhan Ugur Karsli, Turkey & Sangyoun Park, Korea
Photo - https://mma.prnasia.com/media2/2693690/0D3A9497_1.jpg?p=medium600
Photo - https://mma.prnasia.com/media2/2693691/OffRoad_Champion.jpg?p=medium600
Photo - https://mma.prnasia.com/media2/2693692/On_Road_Champion.jpg?p=medium600
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Volvo Trucks Driver Challenge - A step towards Decarbonizing the transportation industry, while maximizing on fuel economy
Volvo Trucks Driver Challenge - A step towards Decarbonizing the transportation industry, while maximizing on fuel economy
Volvo Trucks Driver Challenge - A step towards Decarbonizing the transportation industry, while maximizing on fuel economy
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
